Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SNC PHARMACIE SIMONNET ET JIMENEZ : revenue, balance sheet and financial ratios

SNC PHARMACIE SIMONNET ET JIMENEZ is a French company founded 26 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in FLOIRAC (33270), this company of category PME shows in 2025 a net income positive of 67 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SNC PHARMACIE SIMONNET ET JIMENEZ (SIREN 424857084)
Indicator 2025 2024 2023 2022 2021 2020 2019
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 67 288 € 71 841 € 76 745 € 172 016 € 90 921 € 80 522 € 110 035 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, SNC PHARMACIE SIMONNET ET JIMENEZ generates positive net income of 67 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2025: 110 k€ -> 67 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

67 288 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 69%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

4.275%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

69.449%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

12.0%

Solvency indicators evolution
SNC PHARMACIE SIMONNET ET JIMENEZ

Sector positioning

Debt ratio
4.28 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Excellent

In 2025, the debt ratio of SNC PHARMACIE SIMONNET ET... (4.28) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
69.45% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good +6 pts over 3 years

In 2025, the financial autonomy of SNC PHARMACIE SIMONNET ET... (69.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 138.25. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

138.246

Liquidity indicators evolution
SNC PHARMACIE SIMONNET ET JIMENEZ

Sector positioning

Liquidity ratio
138.25 2025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average +7 pts over 3 years

In 2025, the liquidity ratio of SNC PHARMACIE SIMONNET ET... (138.25) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of SNC PHARMACIE SIMONNET ET JIMENEZ in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SNC PHARMACIE SIMONNET ET JIMENEZ is estimated at 1 068 877 € (range 725 345€ - 1 677 216€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
725k€ 1068k€ 1677k€
1 068 877 € Range: 725 345€ - 1 677 216€
NAF 5 année 2025

Valuation method used

Net Income Multiple
67 288 € × 15.9x = 1 068 878 €
Range: 725 346€ - 1 677 217€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SNC PHARMACIE SIMONNET ET JIMENEZ with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SNC PHARMACIE SIMONNET ET JIMENEZ

What is the revenue of SNC PHARMACIE SIMONNET ET JIMENEZ ?

The revenue of SNC PHARMACIE SIMONNET ET JIMENEZ is not publicly disclosed (confidential accounts filed with INPI).

Is SNC PHARMACIE SIMONNET ET JIMENEZ profitable?

Yes, SNC PHARMACIE SIMONNET ET JIMENEZ generated a net profit of 67 k€ in 2025.

Where is the headquarters of SNC PHARMACIE SIMONNET ET JIMENEZ ?

The headquarters of SNC PHARMACIE SIMONNET ET JIMENEZ is located in FLOIRAC (33270), in the department Gironde.

Where to find the tax return of SNC PHARMACIE SIMONNET ET JIMENEZ ?

The tax return of SNC PHARMACIE SIMONNET ET JIMENEZ is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SNC PHARMACIE SIMONNET ET JIMENEZ operate?

SNC PHARMACIE SIMONNET ET JIMENEZ operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.